Transmission-blocking vaccine of vivax malaria

By Tsuboi T.   Tachibana M.   Kaneko O.   Torii M.  

Parasitology International, Vol. 52, Iss. 1, 2003-03 ,pp. : 1-11

Elsevier

Access to resources Recommend Favorite

Plasmodium vivax:Favored Gene Frequencies of the Merozoite Surface Protein-1 and the Multiplicity of Infection in a Malaria Endemic Region

By Kolakovich K.A.   Ssengoba A.   Wojcik K.   Tsuboi T.   Al-Yaman F.   Alpers M.   Adams J.H.  

Experimental Parasitology, Vol. 83, Iss. 1, 1996-06 ,pp. : 11-18

Elsevier

Access to resources Recommend Favorite

Plasmodium falciparum, P. vivax,andP. malariae:A Comparison of the Active Site Properties of Plasmepsins Cloned and Expressed from Three Different Species of the Malaria Parasite

By Westling J.   Yowell C.A.   Majer P.   Erickson J.W.   Dame J.B.   Dunn B.M.  

Experimental Parasitology, Vol. 87, Iss. 3, 1997-11 ,pp. : 185-193

Elsevier

Access to resources Recommend Favorite

Plasmodium fragile:Efficacy of Arteether ( / ) against Cerebral Malaria Model

By Tripathi R.   Vishwakarma R.A.   Dutta G.P.  

Experimental Parasitology, Vol. 87, Iss. 3, 1997-11 ,pp. : 290-292

Elsevier

Access to resources Recommend Favorite

Plasmodium falciparum: Immunogenicity of Alum-Adsorbed Clinical-Grade TBV25-28, a Yeast-Secreted Malaria Transmission-Blocking Vaccine Candidate

By Gozar M.M.G.   Muratova O.   Keister D.B.   Kensil C.R.   Price V.L.   Kaslow D.C.  

Experimental Parasitology, Vol. 97, Iss. 2, 2001-02 ,pp. : 61-69

Elsevier

Access to resources Recommend Favorite